AAAAAA

   
Results: 1-17 |
Results: 17
Homocysteine - A treatable risk factor for allograft vascular disease after heart transplantation?
Authors: Kutschka, I Pethig, K Struber, M Dieterich, C Harringer, W Haverich, A
Citation: I. Kutschka et al., Homocysteine - A treatable risk factor for allograft vascular disease after heart transplantation?, J HEART LUN, 20(7), 2001, pp. 743-746
Flush perfusion with low potassium dextran solution improves early graft function in clinical lung transplantation
Authors: Struber, M Wilhelmi, M Harringer, W Niedermeyer, J Anssar, M Kunsebeck, A Schmitto, JD Haverich, A
Citation: M. Struber et al., Flush perfusion with low potassium dextran solution improves early graft function in clinical lung transplantation, EUR J CAR-T, 19(2), 2001, pp. 190-194
Combined exogenous surfactant and inhaled nitric oxide therapy for lung ischemia-reperfusion injury in minipigs
Authors: Warnecke, G Struber, M Fraund, S Hohlfeld, JM Haverich, A
Citation: G. Warnecke et al., Combined exogenous surfactant and inhaled nitric oxide therapy for lung ischemia-reperfusion injury in minipigs, TRANSPLANT, 71(9), 2001, pp. 1238-1244
Reversal of severe vasoplegia with single-dose methylene blue after heart transplantation
Authors: Kofidis, T Struber, M Wilhelmi, M Anssar, M Simon, A Harringer, W Haverich, A
Citation: T. Kofidis et al., Reversal of severe vasoplegia with single-dose methylene blue after heart transplantation, J THOR SURG, 122(4), 2001, pp. 823-824
Aerosolized iloprost for severe pulmonary hypertension as a bridge to heart transplantation
Authors: Wittwer, T Pethig, K Struber, M Hoeper, M Harringer, W Haverich, A Franke, U Wahlers, T
Citation: T. Wittwer et al., Aerosolized iloprost for severe pulmonary hypertension as a bridge to heart transplantation, ANN THORAC, 71(3), 2001, pp. 1004-1006
Improved right ventricular function after intracoronary administration of a C1 esterase inhibitor in a right heart transplantation models
Authors: Klima, U Kutschka, I Warnecke, G Kim, P Struber, M Kirschfink, M Haverich, A
Citation: U. Klima et al., Improved right ventricular function after intracoronary administration of a C1 esterase inhibitor in a right heart transplantation models, EUR J CAR-T, 18(3), 2000, pp. 321-327
Low-potassium dextran solution ameliorates reperfusion injury of the long and protects surfactant function
Authors: Struber, M Hohlfeld, JM Fraund, S Kim, P Warnecke, G Haverich, A
Citation: M. Struber et al., Low-potassium dextran solution ameliorates reperfusion injury of the long and protects surfactant function, J THOR SURG, 120(3), 2000, pp. 566-572
Lung transplantation - 10-year experience
Authors: Harringer, W Wiebe, K Struber, M Franke, U Niedermeyer, J Fabel, H Haverich, A
Citation: W. Harringer et al., Lung transplantation - 10-year experience, EUR J CAR-T, 16(5), 1999, pp. 546-553
Exogenous surfactant improves survival and surfactant function in ischaemia-reperfusion injury in minipigs
Authors: Hohlfeld, JM Struber, M Ahlf, K Hoeper, MM Fraund, S Krug, N Warnecke, G Harringer, W Haverich, A Fabel, H
Citation: Jm. Hohlfeld et al., Exogenous surfactant improves survival and surfactant function in ischaemia-reperfusion injury in minipigs, EUR RESP J, 13(5), 1999, pp. 1037-1043
Surfactant replacement in reperfusion injury after clinical lung transplantation
Authors: Struber, M Hirt, SW Cremer, J Harringer, W Haverich, A
Citation: M. Struber et al., Surfactant replacement in reperfusion injury after clinical lung transplantation, INTEN CAR M, 25(8), 1999, pp. 862-864
C1-esterase inhibitor in graft failure after lung transplantation
Authors: Struber, M Hagl, C Hirt, SW Cremer, J Harringer, W Haverich, A
Citation: M. Struber et al., C1-esterase inhibitor in graft failure after lung transplantation, INTEN CAR M, 25(11), 1999, pp. 1315-1318
Inhaled nitric oxide as a prophylactic treatment against reperfusion injury of the lung
Authors: Struber, M Harringer, W Ernst, M Morschheuser, T Hein, M Bund, M Haverich, A
Citation: M. Struber et al., Inhaled nitric oxide as a prophylactic treatment against reperfusion injury of the lung, THOR CARD S, 47(3), 1999, pp. 179-182
Extracorporeal membrane oxygenation - New developments
Authors: Struber, M Haverich, A
Citation: M. Struber et A. Haverich, Extracorporeal membrane oxygenation - New developments, THOR CARD S, 47, 1999, pp. 304-306
Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass
Authors: Struber, M Cremer, JT Gohrbandt, B Hagl, C Jankowski, M Volker, B Ruckoldt, H Martin, M Haverich, A
Citation: M. Struber et al., Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass, ANN THORAC, 68(4), 1999, pp. 1330-1335
Progression of steroid-associated osteoporosis after heart transplantation
Authors: Cremer, J Struber, M Wagenbreth, I Nischelsky, J Demertzis, S Graeter, T Abraham, C Haverich, A
Citation: J. Cremer et al., Progression of steroid-associated osteoporosis after heart transplantation, ANN THORAC, 67(1), 1999, pp. 130-133
Minimally invasive procedures in patients with severe concomitant disease
Authors: Cremer, J Wittwer, T Struber, M Teebken, OE Boning, A Anssar, M Kim, P Zuk, J Mehler, D Haverich, A
Citation: J. Cremer et al., Minimally invasive procedures in patients with severe concomitant disease, CARDIAC SURGERY AND CONCOMITANT DISEASE, 1999, pp. 49-55
ON-X bileaflet valve in aortic position - Early experience shows an improved hemodynamic profile
Authors: Fraund, S Pethig, K Wahlers, T Harringer, W Wiebe, K Struber, M Karck, M Mehler, D Haverich, A
Citation: S. Fraund et al., ON-X bileaflet valve in aortic position - Early experience shows an improved hemodynamic profile, THOR CARD S, 46(5), 1998, pp. 293-297
Risultati: 1-17 |